FDA Science Board Advisory Committee Subcommittee Public Meeting on NARMS, April 10, 2007
CVM’s National Antimicrobial Resistance Monitoring System
Hilton Washington DC/Rockville
Executive Meeting Center
(formerly the DoubleTree Hotel)
1750 Rockville Pike
April 10, 2007,
Beginning at 9:00 a.m.
The Science Board to the FDA (Science Board) National Antimicrobial Resistance Monitoring System (NARMS) Program subcommittee will convene a meeting on April 10, 2007, beginning at 9:00 a.m. at the Hilton Washington DC/Rockville Executive Meeting Center (formerly the DoubleTree Hotel), 1750 Rockville Pike, Rockville, MD 20852. The purpose of the subcommittee will be to evaluate the NARMS program.
The subcommittee will discuss the NARMS Program and hear comments on the NARMS Program, including oral presentations from the public on scope, strengths, weaknesses, and areas for improvement. The subcommittee will provide advice to the Science Board, including information obtained from this public meeting.
Registration requests to attend the meeting should be submitted no later than one day in advance of the meeting, or April 9, 2007. Please see and use the Registration Form posted below.
Requests to make an oral presentation at the meeting must be submitted by March 28, 2007, to Carlos Pena, Office of Science and Health Coordination, Office of the Commissioner (HF–33), Food and Drug Administration, 5600 Fishers Lane, (for express delivery, rm. 14B–08) Rockville, MD 20857, 301–827–3340, e-mail: Carlos.Pena@fda.hhs.gov. Please include a brief statement of the general nature of the evidence or arguments to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make the presentation.
Interested persons may present data, information, or views, orally or in writing, on the issues pending before this subcommittee. Oral presentations from the public will be scheduled at 11:00 a.m. on April 10, 2007.
Transcripts of the meeting may be requested in writing from the Freedom of Information Office (HFI-35), Food and Drug Administration, 5600 Fishers Lane, rm. 6-30, Rockville, MD 20857, at a cost of 10 cents per page.